Medical Developments International reported AUD-36K in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -952K 60K Jun/2026
Avita Medical AUD -6.86M 3.55M Jun/2026
Clinuvel Pharmaceuticals AUD 13.51M 15.95M Dec/2025
Dianthus Therapeutics USD -61.48M 14.95M Jun/2026
Genetic Signatures AUD -6.34M 1.67M Dec/2025
Ionis Pharmaceuticals USD -130M 27.71M Sep/2026
Medical Developments International AUD -36K 444K Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Organon & Co USD 377M 54M Sep/2026
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Starpharma Holdings AUD -873K 1.43M Dec/2025
Tectonic Therapeutic USD -24.22M 3.08M Jun/2026
Telix Pharmaceuticals AUD 46.36M 38.32M Jun/2026
Viatris USD 255.5M 181.8M Sep/2026
Xeris Pharmaceuticals USD 5.17M 2.74M Jun/2026